Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia

NCT06802861 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-09-10

No results posted yet for this study

Summary

This study's primary purpose is to determine the relationship between aspirin metabolism and markers of metabolic dysfunction among patients at risk for preeclampsia.

Conditions

  • Preeclampsia
  • Preeclampsia (PE)
  • Preeclampsia (PE) Risk
  • Obesity and Obesity-related Medical Conditions
  • Pregnancy
  • Pregnancy Complications
  • Gestational Diabetes
  • Gestational Diabetes Mellitus in Pregnancy
  • Gestational Complications

Sponsors & Collaborators

  • University of Tennessee Graduate School of Medicine

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2026-07-31
Completion
2028-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06802861 on ClinicalTrials.gov